Qimoperfusafe is a safety infusion set with Huber needle fitted with a Qimo female for the access of implantable ports.
Product Summary
Qimono the complete closed system for safe delivery of cytotoxic drugs
Stay safe with Qimono
It is widely documented that exposure to Systemic Anti-Cancer Therapy (SACT), can pose a significant health risk to patients during treatment as well as healthcare workers involved in the preparation and administration of the drugs .
Many SACT agents are known to be carcinogenic, teratogenic and mutagenic. Exposure may be through skin contact, skin absorption, inhalation of aerosols and drug particles as well as ingestion and needlestick injuries. This can occur at various points of the treatment process: during the preparation of the medication, whilst the drugs are administered and after therapy .
Adverse health effects reported by chemotherapy nurses include headaches, dizziness, nausea and hair loss.
QimoPerfusafe is a safety infusion device with Huber bevel for implantable ports. QimoPerfusafe is made of: _ 1 needle with Huber bevel, _ 4 wings: 2 upper wings for holding the device during placement and removal. 2 lower wings to hold the implantable port in place when removing QimoPerfusafe and activate the safety device, _ 1 flexible extension tube in polyurethane, length 215 mm _ Int.-ext. ø: 1.5 x 2.5 mm, _ 1 female Luer-lock hub, _ 1 Qimo Female, _ 1 colour-coded clamp according to the size of the needle, _ 1 protection pad. QimoPerfusafe prevents needle-stick injuries by rebound effect when withdrawing a Huber needle from an implantable port. The needle is automatically directed into a safety block offering total protection for health care workers with no change in the handling technique for the operator.
Perfusafe can be used for high pressure injections of contrast medium (CT-scan) up to 350 psi.
Qimo Female is a multi-purpose, closed, needle-free, I.V. connection device. Qimo Female has a very easily disinfectable membrane. See the corresponding technical file code 7210.02.
N.B. Latex-free product compatible with drugs containing lipids (such as Taxol)
UOI Units: 25
Qimono Vascular Access Set
OV7210.01
Regular price
£12.82
/
Qimono Vascular Access Set
Set supplied with Qimo male and Qimoprime in the same packaging.
Set supplied with Qimo male and Qimoprime in the same packaging. To secure both the male Luer-lock and the female Luer-lock end of infusion devices.
Product Summary
Qimono the complete closed system for safe delivery of cytotoxic drugs
Stay safe with Qimono
It is widely documented that exposure to Systemic Anti-Cancer Therapy (SACT), can pose a significant health risk to patients during treatment as well as healthcare workers involved in the preparation and administration of the drugs .
Many SACT agents are known to be carcinogenic, teratogenic and mutagenic. Exposure may be through skin contact, skin absorption, inhalation of aerosols and drug particles as well as ingestion and needlestick injuries. This can occur at various points of the treatment process: during the preparation of the medication, whilst the drugs are administered and after therapy .
Adverse health effects reported by chemotherapy nurses include headaches, dizziness, nausea and hair loss.
Description of the device
Set securing the distal end of the infusion line thanks to Qimo Male and to prime it thanks to QimoPrime.
Qimo Prime is a priming device which can be connected to any product fitted with Qimo Male. See corresponding techical file code 7210.81.
Qimo Male is a multi-purpose, closed, needle-free, I.V. connection device which has been designed for the preparation and safe administration of hazardous drugs. See corresponding techical file code 7210.91.
Qimono QimoTransfer
OV7220.01
Regular price
£22.90
/
Qimono QimoTransfer
Female Luer-lock to female Luer-lock connector, with Qimo female on both ends of the connector.
To transfer medications from syringe to syringe.
Product Summary
Qimono the complete closed system for safe delivery of cytotoxic drugs
Stay safe with Qimono
It is widely documented that exposure to Systemic Anti-Cancer Therapy (SACT), can pose a significant health risk to patients during treatment as well as healthcare workers involved in the preparation and administration of the drugs .
Many SACT agents are known to be carcinogenic, teratogenic and mutagenic. Exposure may be through skin contact, skin absorption, inhalation of aerosols and drug particles as well as ingestion and needlestick injuries. This can occur at various points of the treatment process: during the preparation of the medication, whilst the drugs are administered and after therapy .
Adverse health effects reported by chemotherapy nurses include headaches, dizziness, nausea and hair loss.
Description of the device
Female Luer-lock to female Luer-lock connector, with Qimo Female on both ends of the connector. The main indication of this device is the transfer of drugs from syringe to syringe.
Qimo Female is a multi-purpose, closed, needle-free, I.V. connection device. See the corresponding technical file code 7210.02.
Priming volume: 0.27 ml
Technical Info
Qimono Qimospike V
OV7217.04
Regular price
£27.20
/
Qimono Qimospike V
Qimospike V is a vented spike for vials fitted with Qimo female
Qimospike V is a vented spike for vials fitted with Qimo female
Product Summary
Qimono the complete closed system for safe delivery of cytotoxic drugs
Stay safe with Qimono
It is widely documented that exposure to Systemic Anti-Cancer Therapy (SACT), can pose a significant health risk to patients during treatment as well as healthcare workers involved in the preparation and administration of the drugs .
Many SACT agents are known to be carcinogenic, teratogenic and mutagenic. Exposure may be through skin contact, skin absorption, inhalation of aerosols and drug particles as well as ingestion and needlestick injuries. This can occur at various points of the treatment process: during the preparation of the medication, whilst the drugs are administered and after therapy .
Adverse health effects reported by chemotherapy nurses include headaches, dizziness, nausea and hair loss.
Description of the device
Single use, sterile, needleless device intended for fluid withdrawal. It is recommended for repeated withdrawals from the same vial using a syringe.
QimoSpike V includes a 0.2 µm hydrophobic air-venting fluid filter.
QimoSpike V is fitted with a Qimo Female which will maintain a closed system after perforation of the cap of the vial. It will allow multiple vial access for drug sampling in an aseptic manner. Qimo Female is a multi-purpose, closed, needle-free, I.V. connection device. See the corresponding technical file code 7210.02.
Simple and ergonomic handling.
Code 7217.04: 1 unit in a supple blister. Code 7217.040: Set of 25 QimoSpike V _ 25 units in a supple blister / 100 units in a box / 1200 units in a case
Technical Info
æUOI Units:
Qimono Qimospike
OV7218.11
Regular price
£21.46
/
Qimono Qimospike
Qimospike B is an IV fluid bag access spike fitted with Qimo female.
Qimono is a totally closed system drug transfer device specifically designed to be safe and easy to use by pharmacists and nurses during the infusion of cytotoxic drugs.
Product Summary
Qimono the complete closed system for safe delivery of cytotoxic drugs
Stay safe with Qimono
It is widely documented that exposure to Systemic Anti-Cancer Therapy (SACT), can pose a significant health risk to patients during treatment as well as healthcare workers involved in the preparation and administration of the drugs .
Many SACT agents are known to be carcinogenic, teratogenic and mutagenic. Exposure may be through skin contact, skin absorption, inhalation of aerosols and drug particles as well as ingestion and needlestick injuries. This can occur at various points of the treatment process: during the preparation of the medication, whilst the drugs are administered and after therapy .
Adverse health effects reported by chemotherapy nurses include headaches, dizziness, nausea and hair loss.
Description of the device
Spike for bags of intravenous solutions
Code 7218.01: spike with Qimo Female, for aspirating or adding fluids to bags of intravenous solutions. It can also be used with paediatric bags. The spike perforates the infusion bag while Qimo female maintains at all times a closed system allowing to aspirate or add fluids in an aseptic manner.
Code 7218.11: spike with Qimo Female and non-return valve. This spike is designed for aspiration only of fluid from I.V. bags, but no fluid can be added into the bag. It thus avoids the contamination of the I.V. fluid by drugs.
Qimo Female is a multi-purpose, closed, needle-free, small size I.V. connection device. See the corresponding technical file code 7210.02.
Qimono Qimopump
OV7227.101
Regular price
£17.14
/
Qimono Qimopump
Qimopump is a safe adaptor for pump infusion sets.
Qimopump is a safe adaptor for pump infusion sets. This device is fitted with 1, 2 or 4 Qimo female connectors, a spike with an air-venting port (with a cap) and a universal tube to connect to dedicated pump sets.
Product Summary
Qimono the complete closed system for safe delivery of cytotoxic drugs
Stay safe with Qimono
It is widely documented that exposure to Systemic Anti-Cancer Therapy (SACT), can pose a significant health risk to patients during treatment as well as healthcare workers involved in the preparation and administration of the drugs .
Many SACT agents are known to be carcinogenic, teratogenic and mutagenic. Exposure may be through skin contact, skin absorption, inhalation of aerosols and drug particles as well as ingestion and needlestick injuries. This can occur at various points of the treatment process: during the preparation of the medication, whilst the drugs are administered and after therapy .
Adverse health effects reported by chemotherapy nurses include headaches, dizziness, nausea and hair loss.
Description of the device
QimoPump is a multiple-way connector fitted with Qimo Female ports which is used with IV administration sets (for pumps or gravity administration). QimoPump has a spike with an airventing port fitted with a cap and can have one, two or four lateral ports fitted with Qimo Female connectors. The distal end of QimoPump is compatible with the spike of IV infusion bags.
Code 7227.101: QimoPump 2V _ QimoPump with one lateral port fitted with a Qimo female connector. Code 7227.201: QimoPump 3V _ QimoPump with two lateral ports fitted with a Qimo female connector. Code 7227.401: QimoPump 5V _ QimoPump with four lateral ports fitted with a Qimo female connector.
Qimo Female is a multi-purpose, closed, needle-free, connection device. See the corresponding technical file code 7210.02.
PE lined PVC tubing. The tube is made of 3 layers. The outer layer is in PVC, the inner layer is in Polyethylene without additives, material presenting a high chemical inertness and the intermediate layer is Ethyl Vinyl Acetate, material linking the inner and the outer layers. This structure allows to minimize interaction with drugs and leaching of plasticizers from the PVC into the administered solutions.
Technical Info
æUOI Units: 25 PeræBox
Qimono Qimooctopus
OV7231.221
Regular price
£24.32
/
Qimono Qimooctopus
Qimoharpoon is a closed system transfer device that has an air-intake tube connected
Qimoharpoon is a closed system transfer device that has an air-intake tube connected to a 50ml balloon filled with sterile air which ensures pressure equalisation
Product Summary
imono the complete closed system for safe delivery of cytotoxic drugs
Stay safe with Qimono
It is widely documented that exposure to Systemic Anti-Cancer Therapy (SACT), can pose a significant health risk to patients during treatment as well as healthcare workers involved in the preparation and administration of the drugs .
Many SACT agents are known to be carcinogenic, teratogenic and mutagenic. Exposure may be through skin contact, skin absorption, inhalation of aerosols and drug particles as well as ingestion and needlestick injuries. This can occur at various points of the treatment process: during the preparation of the medication, whilst the drugs are administered and after therapy .
Adverse health effects reported by chemotherapy nurses include headaches, dizziness, nausea and hair loss.
QimoOctopus with Qimo Female and Qimo Male is a multi-purpose catheter accessory, a double lumen IV extension tube with needleless connectors allowing intermittent injections or continuous infusions of fluids or medications. IV extension tube in flexible, transparent polyurethane tubing with a low priming volume. One lumen of QimoOctopus is fitted with a non-return valve, the other lumen is fitted with a Qimo Female connector. The Qimo Male must be connected at the distal end of QimoOctopus.
QimoOctopus has the following advantages: _ Eliminates the risk of access-associated needle-stick injury. _ Reduces the risk of cannula movement in the vein causing mechanical vein irritation. _ Negates the need to use the cannula injection port (non disinfectable), Qimo Female is disinfectable. _ Eliminates the need to use a 3-way tap to run simultaneous compatible solutions. _ Provides closed system (avoiding blood reflux) when accessing the catheter. _ PUR material (no PVC, phthalate-free, no release of plasticizers).
Qimo Female is a multi-purpose, closed, needle-free, connection device with disinfectable membrane. See the corresponding technical file code 7210.02.
Qimo Male is a multi-purpose, closed, needle-free, I.V. connection device which has been designed for the preparation and safe administration of hazardous drugs. See the corresponding technical file code 7210.91.
QimoPrime is priming device. It is used to prime Qimo Male after Qimo Male has been attached onto the distal end of QimoOctopus. See the corresponding technical file code 7210.81.
Qimono Qimoharpoon
OV7213.01
Regular price
£56.02
/
Qimono Qimoharpoon
Qimoharpoon is a closed system transfer device that has an air-intake tube connected
Qimoharpoon is a closed system transfer device that has an air-intake tube connected to a 50ml balloon filled with sterile air which ensures pressure equalisation
Product Summary
Qimono the complete closed system for safe delivery of cytotoxic drugs
Stay safe with Qimono
It is widely documented that exposure to Systemic Anti-Cancer Therapy (SACT), can pose a significant health risk to patients during treatment as well as healthcare workers involved in the preparation and administration of the drugs .
Many SACT agents are known to be carcinogenic, teratogenic and mutagenic. Exposure may be through skin contact, skin absorption, inhalation of aerosols and drug particles as well as ingestion and needlestick injuries. This can occur at various points of the treatment process: during the preparation of the medication, whilst the drugs are administered and after therapy .
Adverse health effects reported by chemotherapy nurses include headaches, dizziness, nausea and hair loss.
Description of the device
QimoHarpoon is a device designed for the reconstitution and withdrawal of high-risk medications. With QimoHarpoon, it is possible to dissolve powdered drugs or lyophilisates and to repeatedly withdraw drugs with a syringe from the same vial/bottle. QimoHarpoon is a needle-free device with a metallic tube (acting as air-intake device) connected to a balloon (50 cc volume). The function of the balloon is to prevent the emission of toxic vapour from the vial and to allow injection and drug aspiration while equalizing pressure in a closed system.
QimoHarpoon is made of: _ a harpoon-shaped spike which perforates the vial/bottle stopper and which cannot be removed from the vial. An opening is located on the harpoon which facilitates injection of the fluid for reconstitution and allows the drawing-up of the final reconstituted solution. From this opening the very last drops of drug can be drawn-up by pulling delicately until the harpoon stops against the cap of the vial. _ a mobile metallic tubing, acting as an air-intake device connected to a balloon filled with sterile air. When this metallic tube is pushed to the bottom of the vial*, the pressure will be equalized and the toxic vapours confined within the balloon. _ a tight protective cover between the base of the spike and the neck of the vial to avoid any contamination with fluids which could leak from the cap of the vial. _ a Qimo Female port, needle-free device, multi-purpose, closed IV connector. Qimo Female can be accessed with any male Luer or Luer-lock syringe or with the Luer bayonet end of Qimo Male. Qimo Female: see technical file code 7210.02. Qimo Male: see technical file code 7210.91.
Code 7213.02: QimoHarpoon _ Adapted for vials with a maximum height of 9 cm. Code 7213.01: QimoHarpoon S _ Adapted for vials with a maximum height of 6 cm.
Qimono QimoConnect Female
OV7221.02
Regular price
£11.38
/
Qimono QimoConnect Female
IV fluid bag extension tube
IV fluid bag extension tube with a lateral injection site fitted with Qimo female and an air-venting port (with a cap).
Product Summary
Qimono QimoConnect
OV7221.0120
Regular price
£12.82
/
Qimono QimoConnect
IV fluid bag extension set with a lateral injection site fitted with Qimo female
Dilution and administration of all kind of medications.
Product Summary
Qimono the complete closed system for safe delivery of cytotoxic drugs
Stay safe with Qimono
It is widely documented that exposure to Systemic Anti-Cancer Therapy (SACT), can pose a significant health risk to patients during treatment as well as healthcare workers involved in the preparation and administration of the drugs .
Many SACT agents are known to be carcinogenic, teratogenic and mutagenic. Exposure may be through skin contact, skin absorption, inhalation of aerosols and drug particles as well as ingestion and needlestick injuries. This can occur at various points of the treatment process: during the preparation of the medication, whilst the drugs are administered and after therapy .
Adverse health effects reported by chemotherapy nurses include headaches, dizziness, nausea and hair loss.
Description of the device
QimoConnect is an extension tube with Qimo Female and Qimo Male ports for pharmacy drugs dilution and administration, with or without filter.
QimoConnect includes the following components: _ 1 spike, _ 1 Qimo Female needleless connector, _ 1 extension tube with clamp, _ 1 Qimo Male needleless connector which must be attached to the distal end of the extension tube after priming of QimoConnect, _ with or without filter ( see hereunder).
PE-lined tubing with external layer in PVC, intermediate layer in EVA and internal layer in PE (featuring chemical inertia and good chemical inertness to medications).
Codes 7221.01 / 7221.020*: QimoConnect Codes 7221.011 / 7221.0110*: QimoConnect filter (0.2 µm) _ See the corresponding technical file Codes 7221.012 / 7221.0120*: QimoConnect air filter _ See the corresponding technical file
Qimo Female is a multi-purpose, closed, needle-free, connection device. See the corresponding technical file code 7210.02.
Qimo Male is a multi-purpose, closed, needle-free, I.V. connection device which has been designed for the preparation and safe administration of hazardous drugs. See the corresponding technical file code 7210.91.
Codes 7221.01 / 7221.011 / 7221.012: 1 unit in a supple blister. Code 7221.020 / 7221.0110 / 7221.0120 _ 7221.020: 10 units in a blister / 100 units in a box / 600 units in a case _ 7221.0110: 10 units in a blister / 100 units in a box / 600 units in a case _ 7221.0120: 10 units in a blister / 100 units in a box / 600 units in a case
* Codes 7221.020 / 7221.0110 / 7221.0120 are supplied without Qimo Male.
Technical Info
æUOI Units: 25 pcs per Box
Contains Latex:æNo
Contains DEHP:æNo
Qimono Qimocap
OV7219.010*
Regular price
£4.20
/
Qimono Qimocap
Qimocap is a vial access cap fitted with Qimo female
Qimocap is a vial access cap fitted with Qimo female. It has been specifically designed to create a permanent connection with the medication vial.
Product Summary
Qimono the complete closed system for safe delivery of cytotoxic drugs
Stay safe with Qimono
It is widely documented that exposure to Systemic Anti-Cancer Therapy (SACT), can pose a significant health risk to patients during treatment as well as healthcare workers involved in the preparation and administration of the drugs .
Many SACT agents are known to be carcinogenic, teratogenic and mutagenic. Exposure may be through skin contact, skin absorption, inhalation of aerosols and drug particles as well as ingestion and needlestick injuries. This can occur at various points of the treatment process: during the preparation of the medication, whilst the drugs are administered and after therapy .
Adverse health effects reported by chemotherapy nurses include headaches, dizziness, nausea and hair loss.
Description of the device
Needleless vial access cap for small vial cap 14 mm (codes 7219.01/010) or large vial cap 20 mm (codes 7219.02/020) with plastic spike. After perforation of the cap of the vial, Qimo Female will avoid the contamination of the drug and will allow multiple vial accesses for drug sampling with a syringe after disinfection of the membrane of Qimo Female.
Qimo Female is a multi-purpose, closed, needle-free, I.V. connection device. See the corresponding technical file code 7210.02.
Codes 7219.01/02: QimoCap _ 1 unit in a supple blister Codes 7219.010/020: Set of 25 QimoCap _ Code 7219.010: 25 units in a supple blister / 100 units in a box / 1 800 units in a case _ Code 7219.020: 25 units in a supple blister / 100 units in a box / 1 200 units in a case
Technical Info
æUOI Units:æBox
Qimono Set
OV7210.04
Regular price
£15.70
/
Qimono Set
Set with Qimoprime, Qimo male and Qimo female in the same packaging.
Can be used to secure the injection site of the elastomeric pump and the distal end of its tubing, but other applications are possible.
Product Summary
Qimono the complete closed system for safe delivery of cytotoxic drugs
Stay safe with Qimono
It is widely documented that exposure to Systemic Anti-Cancer Therapy (SACT), can pose a significant health risk to patients during treatment as well as healthcare workers involved in the preparation and administration of the drugs .
Many SACT agents are known to be carcinogenic, teratogenic and mutagenic. Exposure may be through skin contact, skin absorption, inhalation of aerosols and drug particles as well as ingestion and needlestick injuries. This can occur at various points of the treatment process: during the preparation of the medication, whilst the drugs are administered and after therapy .
Adverse health effects reported by chemotherapy nurses include headaches, dizziness, nausea and hair loss.
Description of the device
Set securing the injection site of an elastomeric pump with Qimo Female and the distal end of its extension tube with Qimo Male. QimoPrime is used to prime the extension tube fitted with Qimo Male.
QimoPrime is a priming device which can be connected to any product fitted with Qimo Male. See corresponding technical file code 7210.81.
Qimo Male is a multi-purpose, closed, needle-free, I.V. connection device which has been designed for the preparation and safe administration of hazardous drugs. See corresponding technical file code 7210.91.
Qimo Female is a multi-purpose, closed, needle-free, I.V. connection device for blood sampling, intermittent injections or continuous infusions of fluids or drugs.
Technical Info
æUOI Units:æBox
UOI:æ50
Contains Latex:
Qimono Qimo Female - Pack of 50
OV7210.02
Regular price
£180.00
/
Qimono Qimo Female - Pack of 50
Qimo female is a multi-purpose, closed, needle-free and disinfectable safety connector.
Qimo female is a multi-purpose, closed, needle-free and disinfectable safety connector.
Product Summary
Qimono the complete closed system for safe delivery of cytotoxic drugs
Stay safe with Qimono
It is widely documented that exposure to Systemic Anti-Cancer Therapy (SACT), can pose a significant health risk to patients during treatment as well as healthcare workers involved in the preparation and administration of the drugs .
Many SACT agents are known to be carcinogenic, teratogenic and mutagenic. Exposure may be through skin contact, skin absorption, inhalation of aerosols and drug particles as well as ingestion and needlestick injuries. This can occur at various points of the treatment process: during the preparation of the medication, whilst the drugs are administered and after therapy .
Adverse health effects reported by chemotherapy nurses include headaches, dizziness, nausea and hair loss.
Description of the device
Qimo Female is a multi-purpose, closed, needle-free, I.V. connection device for blood sampling, intermittent injections or continuous infusions of fluids or drugs. Qimo Female has a very easily disinfectable membrane (disinfection must be carried out before and after use) which closes automatically when the infusion line or the syringe is disconnected.
At the distal end, Qimo Female has a male Luer-lock connection allowing it to be connected to a venous catheter or an I.V. accessory with a female Luer-lock hub (intravenous catheter, extension tube, Huber needle for infusion in an implantable port, stopcock, ramp of stopcocks, spike ƒ). At the proximal end, Qimo Female has a female Luer-lock end, closed thanks to a membrane in polyisoprene. When a venous catheter or an I.V. accessory is fitted with a Qimo Female, Qimo Female can be connected onto: _ the Luer bayonet of Qimo Male (mounted on a syringe, an extension tube or an infusion set), _ a male Luer-lock end (or Luer Slip) of a syringe or an extension tube.
When a Qimo Male or a male Luer end is connected onto Qimo Female, the membrane in polyisoprene moves thanks to a metallic spring and opens an internal conduit allowing the injection, infusion, sampling. When the device is disconnected, the spring pushes back the membrane and automatically closes the device.
Note: for the users who know Vygon Bionector, please note that Qimo Female is in fact a Bionector. The difference lies in the ring with notches allowing to receive the lugs of Qimo Male. Otherwise Qimo Female works like a Bionector.
Qimo Female is resistant to lipid emulsions and antiseptics.
Qimo Female is approved for use with power injectors (CT-scan). Maximum pressure resistance : 350 psi (24 bars). To inject contrast medium products (Visiopaque 320 mg iodine/ml), the flow rate has been measured as such: 35 psi (2.4 bars) : > 5 ml/s 145 psi (10 bars) : > 10 ml/s
Replacement frequency: < 360 connections or 7 days Priming volume: 0.03 ml Flow rate: 105 ml/min
Qimono Qimo Male
OV7210.910*
Regular price
£8.06
/
Qimono Qimo Male
Qimo male is a disinfectable closed needle-free safety connector.
Qimo male is a disinfectable closed needle-free safety connector. It is a safety captive adaptor for male Luer-lock hubs.Once attached, it cannot be disconnected. It connects only to Qimo female .
Product Summary
Qimono the complete closed system for safe delivery of cytotoxic drugs
Stay safe with Qimono
It is widely documented that exposure to Systemic Anti-Cancer Therapy (SACT), can pose a significant health risk to patients during treatment as well as healthcare workers involved in the preparation and administration of the drugs .
Many SACT agents are known to be carcinogenic, teratogenic and mutagenic. Exposure may be through skin contact, skin absorption, inhalation of aerosols and drug particles as well as ingestion and needlestick injuries. This can occur at various points of the treatment process: during the preparation of the medication, whilst the drugs are administered and after therapy .
Adverse health effects reported by chemotherapy nurses include headaches, dizziness, nausea and hair loss.
Description of the device
Qimo Male is a multi-purpose, closed, needle-free, I.V. connection device which has been designed for the preparation and safe administration of hazardous drugs. Qimo Male has a very easily disinfectable membrane (disinfection must be carried out before and after use) which automatically closes when Qimo Female is disconnected.
Qimo Male is a safety adaptor, the proximal end of which must be connected onto the male Luer-lock end of a syringe, an extension tube or an infusion set. At the distal end, the Luer bayonet end can only be connected to devices which feature a Qimo Female end. Note: after the connection of Qimo Male onto a Luer-lock male hub, Qimo Male rotates and cannot be disconnected anymore.
Qimo Male can only be connected to the female Luer bayonet end of Qimo Female, by placing the lugs of Qimo Male into the notches of the bayonet ring of Qimo Female. During the connection, the internal metallic tube of Qimo Female opens both the membranes of Qimo Female and of Qimo Male and the two conduits fit in together. It is then possible to inject, infuse or withdraw samples of drugs. During the disconnection, the membranes automatically close, which ensures the sealing of both devices.
Maximum number of connection: 10 Priming volume: 0.35 ml
Qimo Male is lipid-resistant.
Code 7210.91: Qimo Male _ 1 unit in a supple blister. Code 7210.910: Set of 25 Qimo Male : _ 25 units in a blister / 100 units in a box / 1 800 units in a case
Qimono IV Set - Pack of 25
OV7229.102
Regular price
£475.06
/
Qimono IV Set - Pack of 25
Qimono intravenous infusion device with spike and drip chamber
Intravenous infusion device with spike and drip chamber. It is fitted with 1, 2 or 4 Qimo female and Qimo male to attach to the standard male Luer-lock port at the distal end of Qimo IV set. Qimoprime allows the priming of the line once Qimo male has been attached.
